Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Liver Transplantation clinical trials
Every US clinical trial registered for Liver Transplantation — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
13 US clinical trials · 4 currently recruiting
The research picture
Liver Transplantation has 13 registered US clinical trials, 4 of them open to new participants right now — about 31% of the total.
- 4
- recruiting participants now
- 31%
- of trials open to enrollment
- 4
- in Phase 3–4 (later-stage)
- 1
- top sponsor: Astellas Pharma Europe
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
HOPE Against Cancer Recurrence in HCC
Philipp Dutkowski
NCT06717919
Mediterranean Diet Post-liver Transplantation
Mayo Clinic
NCT04672863
Reducing Pain With Methadone and Ketamine in Liver Transplant
Lahey Clinic
NCT06868589
Immune Tolerance Induction After Liver Transplantation
University of California, Los Angeles
NCT07269041
Molecular Assessment and Profiling of Liver Transplant Recipients
CareDx
NCT04793360
Social & Contextual Impact on Children Undergoing Liver Transplantation
University of California, San Francis
NCT04551742
Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
Organ Recovery Systems
NCT05574361
Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation
Koji Hashimoto
NCT04023773
Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant
Astellas Pharma Europe
NCT02118896
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
Novartis Pharmaceuticals
NCT01888432
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01638559
Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant
University of Miami
NCT01216722
Hemodynamic Measurements During Liver Transplantation
Washington University School of Medicine
NCT00682110
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Liver Transplantation Trial Landscape
ClinicalTrials.gov lists 13 US studies indexed under Liver Transplantation, and 4 of those are currently open to recruitment — roughly 31% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Liver Transplantation shows 4 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Liver Transplantation is led by Astellas Pharma Europe with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 13 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Liver Transplantation?
PlainTrial tracks 13 US clinical trials for Liver Transplantation, of which 4 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Liver Transplantation?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.